Adjunctive Pharmacology for Coronary Intervention

Risk of Restenosis and Health Status Outcomes for Patients Undergoing Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery

Yearbook of Anesthesiology and Pain Management ◽

10.1016/s1073-5437(08)70317-6 ◽

2006 ◽

Vol 2006 ◽

pp. 49-50

Author(s):

M.F. Roizen

Keyword(s):

Percutaneous Coronary Intervention ◽

Health Status ◽

Coronary Artery ◽

Coronary Artery Bypass Graft ◽

Coronary Artery Bypass ◽

Artery Bypass ◽

Bypass Graft ◽

Coronary Intervention ◽

Artery Bypass Graft ◽

Percutaneous Coronary

Download Full-text

409 Haemodynamic parameters in cardiogenic shock due to myocardial infarction: effects of levosimendan compared with dobutamine after primary percutaneous coronary intervention

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(05)80252-8 ◽

2005 ◽

Vol 4 (1) ◽

pp. 92-93

Keyword(s):

Myocardial Infarction ◽

Percutaneous Coronary Intervention ◽

Cardiogenic Shock ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Haemodynamic Parameters ◽

Percutaneous Coronary

Download Full-text

One-Year Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention With Multiple Stenting for Multisystem Disease: A Meta-analysis of Individual Patient Data From Randomized Clinical Trials

Yearbook of Cardiology ◽

10.1016/s0145-4145(07)70157-0 ◽

2006 ◽

Vol 2006 ◽

pp. 254-256

Author(s):

B.J. Gersh

Keyword(s):

Randomized Clinical Trials ◽

Individual Patient Data ◽

Meta Analysis ◽

Artery Bypass ◽

Bypass Graft ◽

Coronary Intervention ◽

Artery Bypass Graft ◽

Multisystem Disease ◽

Percutaneous Coronary ◽

One Year

Download Full-text

P2870 Elective percutaneous coronary intervention using anti-platelet therapy alone, without unfractionated heparin or other anti-thrombin therapy

European Heart Journal ◽

10.1016/s0195-668x(03)95648-x ◽

2003 ◽

Vol 24 (5) ◽

pp. 548

Author(s):

S DENARDO

Keyword(s):

Percutaneous Coronary Intervention ◽

Unfractionated Heparin ◽

Coronary Intervention ◽

Elective Percutaneous Coronary Intervention ◽

Anti Platelet Therapy ◽

Percutaneous Coronary

Download Full-text

P2846 Adverse outcomes in patients experiencing thrombocytopenia following percutaneous coronary intervention: a pooled analysis of abciximab studies

European Heart Journal ◽

10.1016/s0195-668x(03)95624-7 ◽

2003 ◽

Vol 24 (5) ◽

pp. 541

Author(s):

H JAMAL

Keyword(s):

Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Pooled Analysis ◽

Adverse Outcomes ◽

Percutaneous Coronary

Download Full-text

P1627 Does infarct size measured by creatine kinase-MB predict clinical outcomes after fibrinolysis and primary percutaneous coronary intervention?

European Heart Journal ◽

10.1016/s0195-668x(03)94765-8 ◽

2003 ◽

Vol 24 (5) ◽

pp. 301

Author(s):

K MAHAFFEY

Keyword(s):

Percutaneous Coronary Intervention ◽

Creatine Kinase ◽

Infarct Size ◽

Clinical Outcomes ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Creatine Kinase Mb

Download Full-text

P1095 Antecedent thrombolytic therapy followed by planned rescue percutaneous coronary intervention for acute myocardial infarction, compared with primary percutaneous coronary intervention

European Heart Journal ◽

10.1016/s0195-668x(03)94387-9 ◽

2003 ◽

Vol 24 (5) ◽

pp. 197

Author(s):

T HASUDA

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Percutaneous Coronary Intervention ◽

Thrombolytic Therapy ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Percutaneous Coronary

Download Full-text

P1076 Use of IIb/IIIa receptor blockers before and during percutaneous coronary intervention for acute coronary syndromes versus stable angina in consecutive patients in Europe: results of the international SHAKESPEARE registry

European Heart Journal ◽

10.1016/s0195-668x(03)94368-5 ◽

2003 ◽

Vol 24 (5) ◽

pp. 191

Author(s):

A GITT

Keyword(s):

Percutaneous Coronary Intervention ◽

Stable Angina ◽

Acute Coronary Syndromes ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Coronary Syndromes ◽

Receptor Blockers

Download Full-text

2050 Effects of antithrombotic regimen on the early outcome in the FRACAS study: incremental beneficial effects of low molecular weight heparin and thlenopyridine in patients undergoing subsequent percutaneous coronary intervention

European Heart Journal ◽

10.1016/s0195-668x(03)95047-0 ◽

2003 ◽

Vol 24 (5) ◽

pp. 378

Author(s):

M ANGIOL

Keyword(s):

Molecular Weight ◽

Percutaneous Coronary Intervention ◽

Low Molecular Weight Heparin ◽

Coronary Intervention ◽

Low Molecular Weight ◽

Early Outcome ◽

Beneficial Effects ◽

Percutaneous Coronary

Download Full-text

P1101 Simple predictors of outcome in acute myocardial infarctiontreated by primary percutaneous coronary intervention

European Heart Journal ◽

10.1016/s0195-668x(03)94393-4 ◽

2003 ◽

Vol 24 (5) ◽

pp. 198

Author(s):

H TOMODA

Keyword(s):

Percutaneous Coronary Intervention ◽

Primary Percutaneous Coronary Intervention ◽

Coronary Intervention ◽

Predictors Of Outcome ◽

Percutaneous Coronary

Download Full-text